| Name | St Margarets Center |
|---|---|
| Location | 27 Hackett Blvd, Albany, New York |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 92 |
| Occupancy Rate | 90% |
| Medicare ID (CCN) | 335830 |
| Legal Business Name | Center For Disability Service Holding Corporation |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1972663508 |
| Organization Name | CENTER FOR DISABILITY SERVICE HOLDING CORPORATION |
| Doing Business As | ST MARGARET'S CENTER |
| Address | 27 Hackett Blvd, Albany, NY 12208 |
| Phone Number | 518-591-3323 |
News Archive
Peregrine Pharmaceuticals today announced that there will be two presentations, April 4 and 6, at the American Association of Immunologists (AAI) annual meeting in San Diego, California, indicating the anti-viral potential of its Tarvacin antibody. Dr. Melina Soares of The University of Texas Southwestern Medical Center at Dallas will present pre-clinical data titled "Targeting inside-out phospholipids on viruses in a guinea pig model of Lassa fever."
Recent statistics indicate that one in five people worldwide suffer from moderate to severe chronic pain and that one in three are unable or less able to maintain an independent lifestyle due to their pain.
Nearly 30 Americans a day die in vehicle crashes that involve drunk drivers, according to the Centers for Disease Control and Prevention. That number is so appalling to Frank Vahid, a computer science professor in the Bourns College of Engineering at the University of California, Riverside, that he plans to spend much of the rest of his academic career helping to eradicate the problem.
Patient-reported improvements in vision after cataract surgery are high and are unrelated to the level of ocular comorbidity or whether the surgery is in the first or second eye, report researchers.
The Alzheimer's Drug Discovery Foundation announced today that it has awarded a grant of $210,300 to Amicus Therapeutics (Cranbury, NJ) to evaluate small-molecule, orally delivered pharmacological chaperone compounds as a novel approach for treating Alzheimer's disease.
› Verified 4 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Peregrine Pharmaceuticals today announced that there will be two presentations, April 4 and 6, at the American Association of Immunologists (AAI) annual meeting in San Diego, California, indicating the anti-viral potential of its Tarvacin antibody. Dr. Melina Soares of The University of Texas Southwestern Medical Center at Dallas will present pre-clinical data titled "Targeting inside-out phospholipids on viruses in a guinea pig model of Lassa fever."
Recent statistics indicate that one in five people worldwide suffer from moderate to severe chronic pain and that one in three are unable or less able to maintain an independent lifestyle due to their pain.
Nearly 30 Americans a day die in vehicle crashes that involve drunk drivers, according to the Centers for Disease Control and Prevention. That number is so appalling to Frank Vahid, a computer science professor in the Bourns College of Engineering at the University of California, Riverside, that he plans to spend much of the rest of his academic career helping to eradicate the problem.
Patient-reported improvements in vision after cataract surgery are high and are unrelated to the level of ocular comorbidity or whether the surgery is in the first or second eye, report researchers.
The Alzheimer's Drug Discovery Foundation announced today that it has awarded a grant of $210,300 to Amicus Therapeutics (Cranbury, NJ) to evaluate small-molecule, orally delivered pharmacological chaperone compounds as a novel approach for treating Alzheimer's disease.
› Verified 4 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $650 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 18.18 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 3.18 | 5.51 |